Literature DB >> 26541470

Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2.

Righi Valeria1, Schenetti Luisa2, Mucci Adele3, Benatti Stefania2, Tascedda Fabio2, Brunello Nicoletta2, Pariante M Carmine4, Alboni Silvia5.   

Abstract

Interferon (IFN)-α2 is an extensively therapeutically used pro-inflammatory cytokine. Though its efficacy in controlling viral replication and tumor cells proliferation, administration of IFN-α2 is often associated with the development of central side effects. Magnetic resonance spectroscopy studies have demonstrated that IFN-α2 administration affects brain metabolism, however the exact nature of this effect is not completely known. We hypothesized that IFN-α2 can affect metabolic activity of human neuron-like SH-SY5Y cells which possess many characteristics of neurons and represent one of the most used models for studying mechanisms involved in neurotoxicity or neuroprotection. To test our hypothesis we have characterized the metabolic signature of live SH-SY5Y, and their conditioned media, after 24 and 72 h of exposure to vehicle or IFN-α2 (100 ng/ml) by using High Resolution-Magic Angle Spinning (HR-MAS) Nuclear Magnetic Resonance (NMR) spectroscopy. Our results revealed that 1) the use of HR-MAS NMR is ideally suitable for the characterization of the metabolic profile of live cells and their conditioned media without extraction procedures; and 2) a 72 h exposure to IFN-α2 increases the level of metabolites involved in maintaining energetic (including creatine and lactate) and osmotic (such as myo-inositol, scyllo-inositol, taurine and glycerophosphorylcholine) balances in neuron-like cells and of metabolic waste products (namely lactate, ethanol and acetate), glycine and glutamine in their growth media. These results may contribute to gain more knowledge about the IFN-α2 induced effect on the brain and support the interpretation of magnetic resonance spectroscopy studies performed in humans.

Entities:  

Keywords:  HR-MAS NMR; IFN-α; Metabolomics; Neurotoxicity; Osmolytes; SH-SY5Y cells

Mesh:

Substances:

Year:  2015        PMID: 26541470     DOI: 10.1007/s11481-015-9641-x

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  74 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).

Authors:  Dewen Yang; Zhiyong Xie; Diane Stephenson; Daniel Morton; Carol D Hicks; Tracy M Brown; Renuka Sriram; Sharon O'Neill; David Raunig; Thomas Bocan
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

3.  Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.

Authors:  Beathe Sitter; Tone F Bathen; Trond E Singstad; Hans E Fjøsne; Steinar Lundgren; Jostein Halgunset; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2010-01-25       Impact factor: 4.044

4.  Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7 T.

Authors:  B S Hemanth Kumar; Sushanta Kumar Mishra; Poonam Rana; Sadhana Singh; Subash Khushu
Journal:  Behav Brain Res       Date:  2012-03-16       Impact factor: 3.332

5.  Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.

Authors:  Mark G Swanson; Andrew S Zektzer; Z Laura Tabatabai; Jeffry Simko; Samson Jarso; Kayvan R Keshari; Lars Schmitt; Peter R Carroll; Katsuto Shinohara; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

6.  Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

Authors:  Max Dolder; Bernd Walzel; Oliver Speer; Uwe Schlattner; Theo Wallimann
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

7.  Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study.

Authors:  Daniel M Forton; Gavin Hamilton; Joanna M Allsop; Vijay P Grover; Keith Wesnes; Catherine O'Sullivan; Howard C Thomas; Simon D Taylor-Robinson
Journal:  J Hepatol       Date:  2008-04-25       Impact factor: 25.083

8.  Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study.

Authors:  M J Taylor; B Godlewska; J Near; D Christmas; J Potokar; J Collier; P Klenerman; E Barnes; P J Cowen
Journal:  Psychol Med       Date:  2013-05-10       Impact factor: 7.723

9.  Regulation of amyloid precursor protein processing by serotonin signaling.

Authors:  Anna A Pimenova; Amantha Thathiah; Bart De Strooper; Ina Tesseur
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Taurine supplementation reduces oxidative stress and protects the liver in an iron-overload murine model.

Authors:  Zeyu Zhang; Dan Liu; Bo Yi; Zhangping Liao; Lei Tang; Dong Yin; Ming He
Journal:  Mol Med Rep       Date:  2014-09-05       Impact factor: 2.952

View more
  2 in total

Review 1.  Experimental design and reporting standards for metabolomics studies of mammalian cell lines.

Authors:  Sarah Hayton; Garth L Maker; Ian Mullaney; Robert D Trengove
Journal:  Cell Mol Life Sci       Date:  2017-07-01       Impact factor: 9.261

Review 2.  Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.

Authors:  Kim M A De Kleijn; Gerard J M Martens
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.